Drug Summary

  Drug name:  letrozole
  Chemical name:  Letrozole
  Formula:  C₁₇H₁₁N₅
  Weight:   285.3027
  CAS no:  112809-51-5
  DrugBank link:  DB01006
  Description:  
  Indication:  For the extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy. Also for first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. Also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.